Dataciencia

Colección SciELO Chile

Editorial: trends in alcohol use and alcohol-associated liver disease in the US population-authors' reply

Indexado

WoS	WOS:000679688600024
Scopus	SCOPUS_ID:85111670882

DOI

10.1111/APT.16520

Año

2021

Tipo

material editorial

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras

Revista

Revista	ISSN
Alimentary Pharmacology & Therapeutics	0269-2813

Métricas Externas

PlumX	Altmetric	Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Plumx: https://plumanalytics.com/learn/about-metrics/
Altmetric: https://www.altmetric.com/about-altmetrics/what-are-altmetrics/
Dimensions: https://www.dimensions.ai/why-dimensions/

Disciplinas de Investigación

WOS
Gastroenterology & Hepatology
Pharmacology & Pharmacy

Scopus
Pharmacology (Medical)
Hepatology
Gastroenterology

SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional

Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.

Autores - Afiliación

Ord.	Autor	Género	Institución - País
1	Singal, Ashwani K.	-	Univ South Dakota - Estados Unidos Avera Transplant Inst - Estados Unidos Sanford School of Medicine - Estados Unidos Avera Health - Estados Unidos
2	Arsalan, Arshad	Hombre	Univ South Dakota - Estados Unidos Sanford School of Medicine - Estados Unidos
3	Dunn, Winston	Hombre	Kansas Univ - Estados Unidos University of Kansas Medical Center - Estados Unidos
4	Arab, Juanpablo	Hombre	Pontificia Universidad Católica de Chile - Chile Escuela de Medicina - Chile
5	Wong, Robert	Hombre	Universidad de Stanford - Estados Unidos Stanford University - Estados Unidos
6	Kuo, Yong-Fang	Hombre	Univ Texas Med Branch - Estados Unidos UT Medical Branch at Galveston - Estados Unidos The University of Texas Medical Branch at Galveston - Estados Unidos
7	Kamath, P. S.	Hombre	Mayo Clin - Estados Unidos Mayo Clinic - Estados Unidos
8	Shah, Vijay H.	Hombre	Mayo Clin - Estados Unidos Mayo Clinic - Estados Unidos

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento

Fuente
National Institute on Alcohol Abuse and Alcoholism
National Institute of Diabetes and Digestive and Kidney Diseases
Alnylam Pharmaceuticals
American Association for the Study of Liver Diseases
American Porphyria Foundation

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos

Agradecimiento
The authors' declarations of personal and financial interests are unchanged from those in the original article. Dr. Singal reports receiving personal fees from GiLead Pharma, non‐financial support from American Association for Study of Liver Diseases (AASLD), personal fees from American College of Gastroenterology (ACG), grants from ACG, grants from National Institute of Alcohol Abuse and Alcoholism, during the conduct of the study; grants from National Institute of Diabetes and Digestive and Kidney Diseases, personal fees from GiLead Pharmaceuticals, personal fees from Recordati Pharmaceuticals, personal fees from Alnylam Pharmaceuticals , personal fees from Medscape Gastroenterology, personal fees from Chronic Liver Disease Foundation, personal fees from Up‐to‐Date, non‐financial support from American Porphyria Foundation, outside the submitted work. 2

Agradecimiento

The authors' declarations of personal and financial interests are unchanged from those in the original article. Dr. Singal reports receiving personal fees from GiLead Pharma, non‐financial support from American Association for Study of Liver Diseases (AASLD), personal fees from American College of Gastroenterology (ACG), grants from ACG, grants from National Institute of Alcohol Abuse and Alcoholism, during the conduct of the study; grants from National Institute of Diabetes and Digestive and Kidney Diseases, personal fees from GiLead Pharmaceuticals, personal fees from Recordati Pharmaceuticals, personal fees from Alnylam Pharmaceuticals , personal fees from Medscape Gastroenterology, personal fees from Chronic Liver Disease Foundation, personal fees from Up‐to‐Date, non‐financial support from American Porphyria Foundation, outside the submitted work. 2